STAT

SEPTEMBER 21, 2023

The Federal Trade Commission has sued U.S. Anesthesia Partners and its private equity owner, Welsh, Carson, Anderson & Stowe, alleging in federal court the two partners formed a monopoly in order to drive up prices and boost their profits. Normally, the FTC sues the company that it believes has violated antitrust law. But this lawsuit is novel by also going after a private equity sponsor that it believes hatched the entire alleged scheme — and could serve as a warning to other private

Hospitals 357

Hospitals 357

PharmaVoice

SEPTEMBER 19, 2023

This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.

363

363

BioPharma Dive

SEPTEMBER 19, 2023

AIRNA is one of several biotechs to debut plans for target alpha-1 antitrypsin deficiency in recent years, with competitors such as AlveoGene, Wave Life Sciences and Arrowhead Pharmaceuticals.

125

125

The Pharmacist

SEPTEMBER 20, 2023

More than 80,000 patients across mid and south Essex are now monitoring their blood pressure at home as part of an NHS scheme, according to a study by Essex University. BP@home, which was launched nationally in 2020, allows people to monitor their own blood pressure and submit readings to their GP by telephone and email […] The post Home blood pressure service 'success' in Essex appeared first on The Pharmacist.

99

99

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Express Pharma

SEPTEMBER 21, 2023

Bharat Serums and Vaccines hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telangana, in the presence of KT Rama Rao, Minister for IT, E&C, Industries & commerce, MA &UD, Govt. of Telangana. The function was attended by E V Narasimha Reddy IAS, Vice Chairman and MD, TSIIC, Shakthi M Nagappan, CEO, Telangana Lifesciences, Government of Telangana and senior leaders of BSV – Sanjiv Navangul, MD & CEO.

Vaccines 103

Vaccines 103

STAT

SEPTEMBER 21, 2023

Every day at the Kansas clinic where I perform abortions, I take care of pregnant people who have driven 10 hours or more across state lines for their procedures. They’re exhausted after moving mountains to get there: taking time off work, arranging child care, gathering funds. They’re excessively grateful, and their gratitude makes me sad.

276

276

BioPharma Dive

SEPTEMBER 18, 2023

Public health officials, as well as drugmakers, are trying to raise awareness of RSV among older adults at risk, and convince them to get an additional respiratory shot alongside those for COVID and flu.

Vaccines 127

Vaccines 127

Pharmacy Joe

SEPTEMBER 20, 2023

In this episode, I’ll discuss the danger of intubation in the setting of salicylate toxicity. episode854 Subscribe on iTunes , Android , or Stitcher During salicylate toxicity, the movement of salicylate into brain, liver, and other tissues is exacerbated by a low serum pH. This is because the more acidic the pH, the more salicylate becomes nonionized, and the nonionized form is what passes readily into tissues.

Inpatient 98

Inpatient Hospitals 98

Drug Patent Watch

SEPTEMBER 18, 2023

The article “Maximizing the Value of Drug Patents Before Losing Exclusivity” discusses strategies for biomedical companies to maximize the value of their drug patents before the exclusivity period expires. In… The post Maximizing Drug Patents’ Value: Strategies for Biomedical Companies appeared first on DrugPatentWatch - Make Better Decisions.

109

109

STAT

SEPTEMBER 20, 2023

The federal government is again offering free Covid-19 tests to Americans, providing a fifth round of free tests in part to meet current needs, in part to stimulate a domestic testing industry that has struggled with cratering demand for the rapid diagnostics. The measure, announced Wednesday, will see rapid tests released from the Strategic National Stockpile.

363

363

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmaVoice

SEPTEMBER 22, 2023

Despite lower-than-expected demand for a competing treatment, DBV’s chief medical officer says the company’s topical skin patch could be a game-changing option for patients.

130

130

FDA Law Blog: Biosimilars

SEPTEMBER 19, 2023

By Sara W. Koblitz & Kurt R. Karst — Listing patent information in the Orange Book is a matter of judgment, but that judgment call is about to get a bit more scrutiny. On the heels of its powerful (and unprecedented) amicus brief in Paragraph IV litigation between Jazz and Avadel concerning a patent covering a Risk Evaluation and Mitigation Strategy (“REMS”) listed in the Orange Book, the Federal Trade Commission (“FTC”) is gearing up to tackle anticompetitive Orange Book listing practices.

Biosimilars 105

Biosimilars Dosage Communication 105

The Pharmacist

SEPTEMBER 20, 2023

A shortage of pharmacists and pharmacy technicians working in Scotland’s GP-based pharmacotherapy service needs to be urgently addressed, the Royal Pharmaceutical Society (RPS) director for Scotland has told The Pharmacist. Laura Wilson also highlighted the need for long-term workforce planning for pharmacy staff, akin to current work being done by the Scottish Government around planning […] The post Exclusive: Scotland’s pharmacotherapy service needs long-term workforce planning appeared

Pharmacy Technician 90

Pharmacy Technician 90

European Pharmaceutical Review

SEPTEMBER 19, 2023

The European Commission has authorised Apretude ( cabotegravir long-acting (LA) injectable and tablets) for human immunodeficiency virus (HIV) prevention. Cabotegravir LA is indicated in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in high-risk adults and adolescents (at least 12 years of age), weighing at least 35kg.

98

98

STAT

SEPTEMBER 20, 2023

More than three years into the coronavirus pandemic, fewer and fewer people are experiencing their first Covid-19 infections. But as cases climb , those who’ve had the virus before may wonder: What are their chances of developing long Covid — and does the risk increase with each reinfection? Fatigue and brain fog may be the first post-infection symptoms that come to mind for long Covid, but lists compiled by the Centers for Disease Control and Prevention and by the World Health Org

364

364

PharmaVoice

SEPTEMBER 20, 2023

The saga of the anti-parasitic drug continues.

246

246

PioneerRx

SEPTEMBER 19, 2023

Communication is key in the pharmacy industry. Whether you’re talking to patients, doctors, or wholesalers, communication is vital to your pharmacy’s success.

Communication 105

Communication 105

BioPharma Dive

SEPTEMBER 19, 2023

Pharmacy benefit manager lobby PCMA and drugmaker lobby PhRMA pointed fingers over problems in the prescription supply chain during the House committee's second hearing on the PBM industry.

99

99

Pharma Times

SEPTEMBER 18, 2023

The updated vaccines more closely target current circulating variants - News - PharmaTimes

Vaccines 135

Vaccines 135

STAT

SEPTEMBER 20, 2023

Open wide, AI wants a look inside your mouth. A new wave of software is promising to supercharge dentists’ ability to spot decay and bone loss — and propose treatments earlier in the disease process. In just the past three years, eight AI products have gained approval from the Food and Drug Administration. Many more are on the way. These tools in some cases identify lesions years before dentists can see them on X-rays and other images, providing increased treatment opportunities ba

322

322

Express Pharma

SEPTEMBER 20, 2023

Eli Lilly received approval for its dual glucagon-like peptide-1 receptor agonist (GLP-1)/gastric inhibitor polypeptide receptor agonist (GIP) therapy Mounjaro (tirzepatide) in August 2023 for use as a new treatment option for patients in England with type 2 diabetes (T2D), in cases where the existing treatment management options are insufficient. With the recent clinical data that has come out of both the SURMOUNT and SURPASS trials for both T2D and obesity, it is likely that Mounjaro will beco

Diabetes 90

Diabetes 90

Pharmaceutical Technology

SEPTEMBER 20, 2023

The neurotech will receive the investment in Series B equity financing round to invest in Alzheimer’s disease research.

114

114

World Pharma News

SEPTEMBER 18, 2023

Vividion Therapeutics, Inc. (Vividion), announced today that it has initiated dosing of patients in a Phase I oncology clinical trial of its investigational oral Kelch-like ECH Associated Protein 1 (KEAP1) activator, VVD-130037. Vividion is a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, and a wholly owned and independently operated subsidiary of Ba

Immunity 95

Immunity Immunization 95

The Pharmacist

SEPTEMBER 19, 2023

The current funding model for community pharmacy does not contain ‘the right incentives’ to deliver clinical services to patients, a new report outlining a long-term vision for the sector has suggested. A clinical future for the sector, helping to relieve the burden on general practice and other overstretched parts of the health system, formed a […] The post Government should consider funding pharmacies in same way as GPs, report suggests appeared first on The Pharmacist.

Community Pharmacies 80

Community Pharmacies 80

STAT

SEPTEMBER 20, 2023

As the gold rush over weight-loss drugs accelerates, Eli Lilly filed lawsuits against several compounding pharmacies, spas and wellness centers around the U.S. for selling unapproved versions of its Mounjaro diabetes drug, which is frequently used for combating obesity. The drug company accused four compound pharmacies of violating state laws because those versions were not approved by the U.S.

Compounding 294

Compounding Compounding Pharmacies Diabetes 294

Express Pharma

SEPTEMBER 21, 2023

Nitika Pharmaceuticals Specialities, excipient manufacturing company, recently inaugurated its microcrystalline cellulose (*Tabcell) manufacturing plant at Butibori, Nagpur. The company informed that this is India’s largest microcrystalline cellulose manufacturing facility. The inauguration of this manufacturing plant was attended by eminent personalities like Nitin Gadkari – Minister Road Transport and Highways India.

89

89

Pharmaceutical Technology

SEPTEMBER 19, 2023

The company will suspend the development of three assets, considering strategic alternatives for two clinical programmes.

111

111

Pharma Times

SEPTEMBER 18, 2023

The treatment is the first oral GPCR receptor antagonist class recommended for NHS use - News - PharmaTimes

112

112

The Pharmacist

SEPTEMBER 20, 2023

More should be done to ‘support collaboration’ rather than ‘fostering competition’ between different parts of the primary care system, a new report released this week by The King’s Fund and Nuffield Health has said. ‘Frontline’ clinical staff working in primary care such as in community pharmacies and general practice should instead be seen as part […] The post 'Support collaboration’ between community pharmacists and general practice, report urges appeared first on The Pharmacist.

Community Pharmacies 85

Community Pharmacies 85

STAT

SEPTEMBER 19, 2023

Almost half of U.S. states have banned or restricted trans youths’ access to gender-affirming puberty blockers, hormones, and surgery — and many of the same states are also targeting trans youths’ participation in sports. Twenty-three states ban trans youths from participating in school sports consistent with their gender identity, with some laws focusing on students from kindergarten through 12th grade and others including, or exclusively applying to, students at the colleg

361

361

pharmaphorum

SEPTEMBER 20, 2023

Merck puts $1.3bn into AI via Exscientia, BenevolentAI deals Phil.

134

134

Pharmaceutical Technology

SEPTEMBER 19, 2023

Pelican Technology has combined business with Primordial Genetics under a deal to create a private biotechnology company Primrose Bio.

104

104

European Pharmaceutical Review

SEPTEMBER 19, 2023

Kite’s Yescarta ® (axicabtagene ciloleucel) facilitated a high response rate in transplant ineligible relapsed/refractory (R/R) large B-cell lymphoma (LBCL), Phase II study results show. Patients with R/R LBCL who had received one prior line of therapy and were deemed ineligible for high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) were evaluated in the trial.

Chemotherapy 84

Chemotherapy Hospitals 84

PharmaTech

SEPTEMBER 21, 2023

FUJIFILM Diosynth Biotechnologies has finished its new viral vector gene therapy manufacturing facility in Darlington, United Kingdom.

93

93

STAT

SEPTEMBER 19, 2023

The artificial womb, a device aiming to save infants born way too soon, is inching closer to being tested in humans. The technology is close enough to reality that the Food and Drug Administration has decided to convene a two-day panel starting Tuesday to discuss how to best evaluate safety and effectiveness, as well as the ethical quandaries in running clinical trials.

Hospitals 344

Hospitals 344